With ongoing study, there exists a promising potential for the FDA to approve more health-related indications for THC use. An extensive dialogue involving the prescribing or ordering clinician plus the individual is critical, focusing on equally the advantages and possible drawbacks of THC use. Additionally, helpful interprofessional communication